The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-03), Medibank Pvt's 14-Day RSI is 61.69.
The industry rank for Medibank Pvt's 14-Day RSI or its related term are showing as below:
ASX:MPL's 14-Day RSI is ranked worse than 56.64% of 595
companies
in the Insurance industry
Industry Median: 58.92
vs ASX:MPL: 61.69
Medibank Pvt (ASX:MPL) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Medibank Pvt 14-Day RSI Related Terms
ASX:MPL vs FNF, AXS, FAF: 14-Day RSI Comparison
For the Insurance - Specialty subindustry, Medibank Pvt's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medibank Pvt 14-Day RSI vs Insurance Industry
For the Insurance industry and Financial Services sector, Medibank Pvt's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Medibank Pvt's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medibank Pvt (ASX:MPL) has a 14-Day RSI of 61.69 as of Jul. 03, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medibank Pvt and its competitors. According to the industry distribution chart, Medibank Pvt ranks #337 out of 595 companies in the Insurance industry, placing it in the top 56.6%.
Is Medibank Pvt's 14-Day RSI too high?
Medibank Pvt's current 14-Day RSI is 61.69. The Insurance industry median 14-Day RSI is 58.92. Medibank Pvt's value of 61.69 is 4.7% above this industry median. Based on the distribution chart, Medibank Pvt ranks #337 out of 595 companies in the Insurance industry, which is below the industry midpoint. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's 14-Day RSI compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #337 out of 595 companies for 14-Day RSI. This places Medibank Pvt in the lower half of its industry. The industry median 14-Day RSI is 58.92. Medibank Pvt's value of 61.69 is 4.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for an Insurance company?
The median 14-Day RSI among Insurance companies is 58.92, based on 595 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medibank Pvt's current 14-Day RSI of 61.69 is 4.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Medibank Pvt and its competitors. For the Insurance industry, the median 14-Day RSI is 58.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current 14-Day RSI is 61.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.39, compared to a current price of A$5.00 — trading 13.9% above its estimated fair value. The current 14-Day RSI is 61.69 and 4.7% above the Insurance industry median of 58.92. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current 14-Day RSI is 61.69 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medibank Pvt (ASX:MPL) Overvalued in 2026?
Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued.
The current stock price of A$5.00 is trading 13.9% above its estimated GF Value™ of A$4.39.
GuruFocus considers Medibank Pvt to be Modestly Overvalued.
Key valuation signals for ASX:MPL:
14-Day RSI: 61.69
GF Value™: A$4.39 vs. price of A$5.00 (13.9% above fair value)
Industry Position: 4.7% above the Insurance median (#337 of 595)
No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score
Get the complete analysis for ASX:MPL
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MPL has been successfully added to your 